El Paso, TXNCT07410117Now EnrollingIRB Ready

Cancer-Associated Thrombosis (CAT) Clinical Trial in El Paso, TX

Access cutting-edge cancer-associated thrombosis (cat) treatment through this clinical trial at a research site in El Paso. Study-provided care at no cost to qualified participants.

Sponsored by Regeneron Pharmaceuticals

Quick Self-Assessment

See if you qualify for this El Paso location

Preparing your pre-screening questions…

Expert Care in El Paso

Access cancer-associated thrombosis (cat) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cancer-associated thrombosis (cat) treatment provided free

Apply for This El Paso Location

Check if you qualify for this cancer-associated thrombosis (cat) clinical trial in El Paso, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to El Paso

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit El Paso site if eligible
  4. 4Begin participation

About This Cancer-Associated Thrombosis (CAT) Study in El Paso

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CAT) in participants. The aim of the study is to see how effective the study drug is in preventing blood clots in participants with solid tumors who are currently receiving anticancer treatment or planning to start anticancer treatment within a month of being assigned to a study treatment, or recovering from surgery, and how the study drug compares to placebo for CAT. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

Sponsor: Regeneron Pharmaceuticals

Who Can Participate

Inclusion Criteria

Has a histologically confirmed diagnosis of malignant solid tumors which are locally advanced or metastatic as described in the protocol
Has a Khorana thromboembolic risk score ≥2 during screening period or harbors a somatic documented tumor genetic variant known to be associated with a similar increased risk of VTE as described in the protocol
Has an Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2 at the time of screening and day 1 prior to the first dose of study intervention Key

Exclusion Criteria

Has known bleeding conditions (eg, Hemophilia A or B, von Willebrand's disease), hemorrhagic tumor sites, or other conditions with a high risk for bleeding (eg, hepatic disease associated with coagulopathy)
Has a cancer diagnosis consisting solely of basal cell or squamous cell skin carcinoma
Has a primary brain tumor or brain metastases as described in the protocol
Has proximal lower extremity DVT locally detected by Compression Ultrasound (CUS) during screening period
Has any condition that, as judged by the investigator, may confound the results of the study or would place the participant at increased risk of harm if he/she participated in the study Note: Other Protocol Defined Inclusion/ Exclusion Criteria Apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in El Paso?

Yes, this clinical trial (NCT07410117) has an active research site in El Paso, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cancer-Associated Thrombosis (CAT) Treatment Options in El Paso, TX

If you're searching for cancer-associated thrombosis (cat) treatment options in El Paso, TX, this clinical trial (NCT07410117) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our El Paso research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer-associated thrombosis (cat) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cancer-associated thrombosis (cat) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in El Paso, TX

See all ankylosing spondylitis clinical trials recruiting in El Paso — not just this study.

Browse Ankylosing Spondylitis Trials in El Paso →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsErectile Dysfunction TrialsVenous Thromboembolism TrialsAll Conditions →

Ready to Join in El Paso?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · El Paso, TX